ATE75608T1 - Arzeimittel. - Google Patents

Arzeimittel.

Info

Publication number
ATE75608T1
ATE75608T1 AT87900101T AT87900101T ATE75608T1 AT E75608 T1 ATE75608 T1 AT E75608T1 AT 87900101 T AT87900101 T AT 87900101T AT 87900101 T AT87900101 T AT 87900101T AT E75608 T1 ATE75608 T1 AT E75608T1
Authority
AT
Austria
Prior art keywords
pct
sec
date
medications
pub
Prior art date
Application number
AT87900101T
Other languages
German (de)
English (en)
Inventor
Hansjoerg Eibl
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE75608T1 publication Critical patent/ATE75608T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
AT87900101T 1985-12-04 1986-12-04 Arzeimittel. ATE75608T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3542893 1985-12-04
DE3606631 1986-02-28
PCT/EP1986/000706 WO1987003478A2 (en) 1985-12-04 1986-12-04 Medicaments
EP87900101A EP0248062B1 (de) 1985-12-04 1986-12-04 Arzeimittel

Publications (1)

Publication Number Publication Date
ATE75608T1 true ATE75608T1 (de) 1992-05-15

Family

ID=25838509

Family Applications (2)

Application Number Title Priority Date Filing Date
AT87900101T ATE75608T1 (de) 1985-12-04 1986-12-04 Arzeimittel.
AT86906829T ATE64529T1 (de) 1985-12-04 1986-12-04 Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT86906829T ATE64529T1 (de) 1985-12-04 1986-12-04 Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.

Country Status (15)

Country Link
US (2) US4837023A (show.php)
EP (4) EP0248047B1 (show.php)
JP (2) JPH0637393B2 (show.php)
AT (2) ATE75608T1 (show.php)
CA (2) CA1280369C (show.php)
DE (4) DE19375061I2 (show.php)
DK (2) DK172954B1 (show.php)
ES (2) ES2032755T3 (show.php)
FI (2) FI873363A7 (show.php)
GR (2) GR3002487T3 (show.php)
HU (2) HU203201B (show.php)
IE (2) IE59778B1 (show.php)
NO (2) NO175620C (show.php)
PT (2) PT83872B (show.php)
WO (2) WO1987003480A2 (show.php)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916884A (en) * 1985-12-04 1999-06-29 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Compositions containing a mixture of phosphorus compounds and alkylglycerols
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
US5182271A (en) * 1989-08-10 1993-01-26 Sandoz Ltd. Thioether, keto-ester and alkyl phospholipids useful in treating multiple sclerosis
ATE137973T1 (de) * 1989-08-10 1996-06-15 Sandoz Ag Phospholipide zur behandlung der multiplen sklerose
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
US5369097A (en) * 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
US5506217A (en) * 1991-04-25 1996-04-09 The University Of British Columbia Phosphonates as anti-cancer agents
DE59208905D1 (de) * 1991-07-04 1997-10-23 Asta Medica Ag Verfahren zur Herstellung von Alkylphosphocholinen und Reinherstellung derselben
US6254879B1 (en) 1991-09-27 2001-07-03 Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V. Methods of treating protozoal diseases
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs
US6172050B1 (en) 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
DE4222910A1 (de) * 1992-07-11 1994-01-13 Asta Medica Ag Neue Phospholipidderivate
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
CA2164717C (en) * 1993-06-10 2009-10-20 Louis S. Kucera Method of combatting hepatitis b virus infection
KR100260110B1 (ko) 1993-09-09 2000-07-01 라카일레 지. 필리페 담즙으로부터 추출된 면역조절제 조성물
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
AU3216695A (en) * 1994-08-29 1996-03-22 University Of North Carolina At Chapel Hill, The Lipid analogs for treating viral infections
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US5574025A (en) * 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
AU1573495A (en) * 1995-02-10 1996-08-27 University Of British Columbia, The {4-hexadecyl-3-methoxy-butyl} phosphonic acid and its protienconjugates useful as anti-cancer agents
BR9607967A (pt) 1995-03-16 1998-01-13 Imutec Pharma Inc Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US6121245A (en) * 1997-01-29 2000-09-19 Firshein; Richard N. Method of treating cancer using alkylglycerols in conjunction with chemotherapy
SE9701912D0 (sv) * 1997-05-22 1997-05-22 Interhealth Ab Pharmaceutical composition and use thereof
US7582678B2 (en) * 1997-07-09 2009-09-01 D-Pharm Limited Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
SK284839B6 (sk) * 1998-01-22 2005-12-01 Zentaris Gmbh Použitie miltefozínu na výrobu lieku a farmaceutická kombinácia na liečenie leishmanózy
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
IL137672A0 (en) * 2000-08-03 2001-10-31 Dpharm Ltd Derivatives of branched-chain lipophilic molecules and uses thereof
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
KR20030041130A (ko) * 2001-05-29 2003-05-23 코닌클리케 필립스 일렉트로닉스 엔.브이. 금속-세라믹 접착
KR100871648B1 (ko) * 2001-08-31 2008-12-03 톰슨 라이센싱 조건부 액세스 시스템을 구현하는 방법, 컨텐트를 전송하는 방법 및 그 장치 및 컨텐트를 수신하고 처리하는 방법 및 그 장치
WO2003090757A1 (en) * 2002-04-26 2003-11-06 Rudolf Perl Pharmaceutical compositions of phospholipid derivatives
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
KR101378005B1 (ko) 2005-12-19 2014-03-27 아에테르나 젠타리스 게엠베하 세포독성이 감소된 알킬 인지질 유도체 및 이의 용도
ES2391226T3 (es) * 2006-12-20 2012-11-22 Alphaptose Gmbh Forma farmacéutica tópica que comprende compuestos de glicerol tri-sustituido
JP2011057647A (ja) * 2009-09-14 2011-03-24 Adeka Corp 化粧料
KR102164567B1 (ko) 2011-06-24 2020-10-12 쥐알아이 바이오,아이엔씨. 염증 질환의 예방 및 치료
CN102491994B (zh) * 2011-12-07 2014-10-15 宁波九胜创新医药科技有限公司 一种胆碱磷酸烷基酯的制备方法
KR102665487B1 (ko) * 2014-12-09 2024-05-10 쥐알아이 바이오,아이엔씨. 염증 질환의 예방 및 치료

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225227A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Derivate des n.n-bis-(2-chlor-aethyl)-phosphorsaeureamids
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
JPS60184092A (ja) 1984-03-01 1985-09-19 Kao Corp リン酸エステルおよびその製法

Also Published As

Publication number Publication date
JPH0637393B2 (ja) 1994-05-18
US4837023A (en) 1989-06-06
NO174877C (no) 1994-07-27
DE3679908D1 (de) 1991-07-25
HU203201B (en) 1991-06-28
FI873363A0 (fi) 1987-08-03
DK393187A (da) 1987-07-28
NO175620B (show.php) 1994-08-01
PT83872B (pt) 1989-01-17
EP0248062B1 (de) 1992-05-06
EP0248062A1 (de) 1987-12-09
CA1280369C (en) 1991-02-19
EP0225608A2 (de) 1987-06-16
FI873364A7 (fi) 1987-08-03
WO1987003480A3 (en) 1988-02-25
NO873244L (no) 1987-10-01
ATE64529T1 (de) 1991-07-15
DE19375061I2 (de) 2008-11-20
IE59778B1 (en) 1994-04-06
FI873363L (fi) 1987-08-03
NO873243D0 (no) 1987-08-03
US5049552A (en) 1991-09-17
NO873243L (no) 1987-10-02
HUT44441A (en) 1988-03-28
JP2857084B2 (ja) 1999-02-10
PT83873B (pt) 1989-01-17
DK398587D0 (da) 1987-07-30
EP0230575A3 (de) 1987-12-02
NO174877B (no) 1994-04-18
HUT44431A (en) 1988-03-28
GR3002487T3 (en) 1992-12-30
PT83872A (de) 1987-01-01
JPS63501719A (ja) 1988-07-14
DK398587A (da) 1987-07-30
WO1987003480A2 (en) 1987-06-18
ES2032755T3 (es) 1993-03-01
JPH0859677A (ja) 1996-03-05
WO1987003478A2 (en) 1987-06-18
DK172954B1 (da) 1999-10-18
NO873244D0 (no) 1987-08-03
IE59777B1 (en) 1994-04-06
DE3641379A1 (de) 1987-09-03
EP0225608A3 (de) 1987-10-28
CA1338627C (en) 1996-10-01
EP0248047B1 (de) 1991-06-19
ES2038215T3 (es) 1993-07-16
EP0248047A1 (de) 1987-12-09
HU208143B (en) 1993-08-30
EP0230575A2 (de) 1987-08-05
PT83873A (de) 1987-01-01
IE863177L (en) 1987-06-04
NO175620C (no) 1994-11-09
GR3005168T3 (show.php) 1993-05-24
FI873364A0 (fi) 1987-08-03
FI873363A7 (fi) 1987-08-03
WO1987003478A3 (en) 1987-09-24
IE863176L (en) 1987-06-04
DE3641491A1 (de) 1987-09-17
DK393187D0 (da) 1987-07-28

Similar Documents

Publication Publication Date Title
ATE75608T1 (de) Arzeimittel.
FI873113L (fi) Tvaettmedelskomposition.
FI863362A7 (fi) Farmaseuttinen koostumus.
DE3887513D1 (de) Chemische formulierungen.
DE3785303D1 (de) Ampullenverpackung.
FI885026L (fi) Haorvaordsmedel.
DE3668129D1 (de) Xy-tisch.
FI883673A0 (fi) Farmaceutiska kompositioner.
IT1213453B (it) Composizione farmaceutica.
NO822841L (no) Insekticid middel med virkning mot bladlus.
LV10870A (lv) Jauni fosfolipidu atvasinajumi
NO873628D0 (no) 2,3-dihydro-1h-fenalen-2-amino-forbindelser som antipsykotiske legemidler.
NO871229D0 (no) Farmasoeytisk blanding som inneholder oksazepam.
FI892187L (fi) Kylfoerpackning.
FI830653A7 (fi) Diabeteslääkeseoksia.
IT8530728V0 (it) Ago per pneumoperitoneo (agopnp).
ES1004779Y (es) Cortador de ampollas.
IT8222611A0 (it) Composizione farmaceutica disintossicante.
IT8520272A0 (it) Composizione farmaceutica.
NO874743D0 (no) Terapeutiske blandinger for veterinaerbruk.
IT208775Z2 (it) Siringa per l'anestesia intraligamentosa.
IT1210498B (it) Portadeodorante per ambienti.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee